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Abstract 
Background: An important question is whether evolution favors properties such as 
mutational robustness or evolvability that do not directly benefit any individual but can 
influence the course of future evolution. Functionally similar proteins can differ 
substantially in their robustness to mutations and capacity to evolve new functions, but it 
has remained unclear whether any of these differences might be due to evolutionary 
selection for these properties. 
Results: Here, we use laboratory experiments to demonstrate that evolution favors 
protein mutational robustness if the evolving population is sufficiently large. We 
neutrally evolve cytochrome P450 proteins under identical selection pressures and 
mutation rates in populations of different sizes, and show that proteins from the larger 
and thus more polymorphic population tend towards higher mutational robustness. 
Proteins from the larger population also evolve greater stability, a biophysical property 
that is known to enhance both mutational robustness and evolvability. The excess 
mutational robustness and stability is well described by mathematical theory, and can be 
quantitatively related to the way that the proteins occupy their neutral network. 
Conclusions: Our work is the first experimental demonstration of the general tendency 
of evolution to favor mutational robustness and protein stability in highly polymorphic 
populations. We suggest that this phenomenon could contribute to the mutational 
robustness and evolvability of viruses and bacteria that exist in large populations. 
Background 
Proteins are quite tolerant of mutations, allowing evolution to produce highly diverged 
sequences that fold to similar structures and perform conserved biochemical 
functions [1,2]. However, proteins with nearly identical structures and functions can 
differ in their robustness to mutation [3-5], as well as in their capacity to acquire new 
functions [5]. The fact that mutational robustness and evolvability can vary among the 
functionally equivalent proteins produced by natural sequence divergence makes these 
properties important hidden dimensions in evolution – direct selection for protein 
function is blind to them, yet they can play a crucial role in enabling future evolution. 
Whether the evolutionary process somehow promotes the acquisition of mutational 
robustness and evolvability therefore remains a major question [6-8]. 
Previous experiments have identified several specific evolutionary conditions that can 
affect mutational robustness. For example, genetic complementation decreases the 
mutational robustness of viruses [9], while high mutation rates favor mutational 
robustness in simulated digital organisms [10]. However, theory [11] makes the much 
broader – and previously experimentally untested – prediction that extra mutational 
robustness will arise quite generally in sufficiently large populations. This prediction 
cannot be understood in the standard framework of Kimura’s neutral theory [12], because 
one of the usual assumptions of the neutral theory is that mutational robustness is 
constant. (Although Takahata [13] treated the consequences of stochastically fluctuating 
neutrality on the molecular clock, he did not describe how mutational robustness might 
change systematically during evolution.) However, changes in mutational robustness can 
be described by envisioning evolution as occurring on neutral networks, or sets of 
functionally equivalent proteins that are connected by single mutational steps [14-17]. In 
a seminal theoretical analysis of evolution on neutral networks, van Nimwegen and 
coworkers [11] predicted that the extent of mutational robustness should depend on the 
degree of population polymorphism. Here, we briefly summarize their reasoning, as it 
motivates our experimental work. We also refer the reader to chapter 16 of Wagner [8], 
which contains an excellent explanation of the densely mathematical work of van 
Nimwegen and coworkers [11]. 
If an evolving population is mostly monomorphic, then each mutation is either lost or 
goes to fixation before another mutation occurs. The population is therefore usually 
clustered at a single genotype and rarely experiences mutations, meaning that selection 
does not distinguish between genotypes of different mutational robustness. The evolving 
population can be envisioned a single walker on the neutral network, and although the 
population is less likely to move to poorly-connected nodes of the neutral network, when 
it does reach such nodes it will tend to remain “stuck” at them for long periods of time 
(the population behaves as in the “blind ant” walk described in [11]). As a result, a 
mostly monomorphic population occupies all neutral network nodes with equal 
probability [11]. By contrast, a highly polymorphic population is always spread across 
many nodes of the neutral network. When mutations occur, the members of the 
population at highly connected nodes have a better chance of surviving, causing them to 
be favored by evolution and increasing the average mutational robustness [11,17-20]. 
Specifically, a highly polymorphic population occupies each node with a probability 
proportional to its eigenvector centrality [11,17], a measure of how connected it is to 
other connected nodes (a variant of eigenvector centrality is used by Google’s PageRank 
algorithm to rank a webpage’s importance in the network of internet links [21]). Figure 
1A illustrates how mostly monomorphic and highly polymorphic populations are 
predicted to occupy a neutral network. The preference of highly polymorphic populations 
for more connected neutral network nodes leads to an increase in the average mutational 
robustness, as a node’s connectivity is proportional to its robustness to single mutations. 
For proteins, this preference for excess mutational robustness in highly polymorphic 
populations can also be seen in the stabilities of the evolved proteins [22]. The basic idea 
is that selection for protein function imposes a roughly threshold requirement on protein 
stability, with proteins able to perform their biochemical functions if, and only if, they are 
more stable than some minimal threshold. Extra stability beyond the threshold confers no 
direct benefit on a protein’s function, but it does increase the protein’s mutational 
robustness by allowing it to tolerate a wider range of destabilizing mutations (as has been 
experimentally verified for three different enzymes [3-5]). The preference for protein 
mutational robustness in highly polymorphic populations is therefore predicted to be 
manifested by higher average stability of proteins evolving in such populations [22]. 
Figure 1B illustrates how proteins from highly polymorphic populations are predicted to 
be more stable than their counterparts from mostly monomorphic populations. Note that 
the extent of polymorphism depends on the product of the mutation rate and population 
size, meaning that proteins from populations of different sizes are predicted to evolve to 
different levels of mutational robustness and stability even if they experience the same 
mutation rate. 
Results and Discussion 
Design of neutral evolution experiment 
To test whether high population polymorphism drives an increase in mutational 
robustness and protein stability, we performed laboratory evolution experiments on 
cytochrome P450 proteins. The basic idea was to neutrally evolve P450s under a constant 
selection pressure in populations that were either monomorphic or highly polymorphic, 
and observe whether the proteins evolved to different levels of mutational robustness and 
stability. The evolution experiments started with a P450 BM3 heme domain that had been 
engineered to hydroxylate 12-p-nitrophenoxydodecanoic acid (12-pNCA) [23]. We 
imposed the selection criterion that Escherichia coli cells expressing the P450 had to 
yield lysate with enough active enzyme to hydroxylate a specified amount of 12-pNCA in 
40 min. This criterion roughly corresponds to the case in which an enzyme must catalyze 
a biochemically relevant reaction at some minimal level in order for its host to survive. 
Note that other properties such as stability and expression level can vary freely, provided 
that the criterion for total activity is met.  
The properties of a neutrally evolving protein eventually “equilibrate,” much as the 
properties of an isolated physical system under some macroscopic constraint tend 
towards the values that maximize the system’s internal entropy. For proteins, this usually 
means that stability, expression, and activity drift towards their lowest tolerable values, as 
the vast majority of random sequences do not encode stable, well expressed enzymes 
(that is, natural selection must work against sequence entropy to maintain a functional 
protein) [22,24]. The initial P450 had been engineered for maximal activity [23], 
meaning that it was not equilibrated to the more mild selection criterion of the 
experiments. We therefore neutrally evolved this initial P450 for 16 generations, 
introducing random mutations with error-prone PCR and retaining all mutants that met 
the selection criterion for total activity on 12-pNCA. The procedure used for this 
equilibration evolution was similar to that used for the polymorphic neutral evolution 
described below. As expected, expression, stability, and activity all dropped during the 
equilibration evolution. At the end of the equilibration evolution, we chose a single 
sequence as the parent for the neutral evolution experiments. The gene encoding this 
parent sequence contained 29 nucleotide mutations and 13 amino acid mutations relative 
to the initial P450 (Additional file 1).  
We used this parent gene to begin three parallel sets of neutral evolution experiments, 
which we named “monomorphic,” “polymorphic,” and “unselected” (Figure 2). The 
monomorphic experiments capture the case where the population moves as a single 
entity, the polymorphic experiment captures the case where the population spreads across 
many sequences, and the unselected experiments show how the gene evolves in the 
absence of selection for protein function. In all experiments, at each generation we used 
error-prone PCR to introduce an average of 1.4 nucleotide mutations per P450 gene 
(Table 1). The mutant genes were ligated into a plasmid and transformed into E. coli [25], 
and transformants were selected using the plasmid’s antibiotic resistance marker. For the 
unselected case, we randomly picked one of the mutants, recovered the mutant gene with 
a plasmid mini-prep, and used this mutant as the template for the next generation of error-
prone PCR. We performed four independent replicates of unselected evolution, evolving 
each for 12 generations.  
For the monomorphic and polymorphic populations, we imposed the selection criterion 
that the P450s hydroxylate 12-pNCA with at least 75% of the total activity of the original 
parent gene. We expressed the P450s in E. coli, and then assayed the cell lysates for 
activity in a high-throughput 96-well plate format. The total amount of product produced 
by 80 µl of clarified lysate in 40 min was compared to the median of four control wells 
containing the original parent P450 to determine if the mutant met the selection criterion. 
The only difference between the monomorphic and polymorphic experiments was the 
size of the evolving populations. In the monomorphic limit, each mutation is either lost or 
goes to fixation before the next occurs. We enforced this evolutionary dynamic by 
holding the population size to a single protein sequence. At each generation, we assayed a 
single mutant. If this mutant met the selection criterion, then it was carried over to the 
next generation, corresponding to a neutral mutation going to fixation. If the mutant 
failed the selection criterion, then the population stayed at the previous sequence for the 
next generation, corresponding to a mutation lost to selection. The fact that we retained 
the previous sequence when a nonfunctional mutant was screened is critical, as it made 
the protocol correspond to the case of a mostly monomorphic population where the 
genotype is unchanged if a nonfunctional mutant is produced (if instead a functional 
variant was selected at each generation, the protocol would then correspond to the 
“myopic ant” walk of [11], and would no longer reproduce the behavior of a mostly 
monomorphic population). If all of the mutants assayed had zero or one mutations, then 
this protocol would correspond exactly to the “blind ant” walk of [11] or the Nµ<<1 
equations of [22]. However, in order to achieve appreciable sequence evolution on a 
laboratory time scale, we used a mutation rate that sometimes produced multiple 
mutations in a generation. We mathematically describe this situation in the Appendix; 
here we simply note that it is possible to think of each generation as introducing a single 
mutational event rather than a single mutation. We performed 22 independent replicates 
of monomorphic evolution, evolving each for 25 generations.  
In the polymorphic limit, the population spreads across many sequences. To implement 
this experimentally, we assayed 435 mutants at each generation. The selection criterion 
was used to classify each mutant as functional or nonfunctional. In neutral evolution, all 
functional mutants reproduce with equal probability. We therefore pooled equal volumes 
of stationary-phase cultures of each functional mutant and recovered the pooled genes 
with a mini-prep. The polymorphic evolution experiment therefore approaches the 
equations of [11,22], again with the exception that a sequence might undergo multiple 
mutations at a single generation. We give the equations describing this situation in the 
Appendix. The mutational robustness of a sufficiently large population is expected to 
evolve deterministically [11,22], so we only performed a single polymorphic replicate 
(evidence that the experiment was near the deterministic regime is seen below from the 
fact that the mutational robustness was roughly constant). Because mutations accumulate 
more rapidly in the polymorphic experiments than the monomorphic ones, we evolved 
the polymorphic population for 15 generations rather than 25. 
Mutations and mutational robustness 
Figure 3 shows how mutations accumulated during the course of the neutral evolution 
experiments (full data are given in Table 2 and Additional file 2). Because the unselected 
protein populations evolve without constraint, mutations accumulate at the same rate at 
which they are introduced by error-prone PCR, 1.4 nucleotide mutations per generation. 
Because selection eliminates mutations that disrupt P450 activity, mutations accumulate 
more slowly in the monomorphic and polymorphic populations. Mutations accumulate 
more rapidly in the polymorphic population than in the monomorphic populations. This 
difference in rates is predicted by the equations in the Appendix to be a consequence of 
the fact that the polymorphic population is more mutationally robust, and so can tolerate 
more of the possible mutations.  
To test directly whether the polymorphic population evolves higher average mutational 
robustness, we measured the fraction of 435 random mutants that met the selection 
criterion. Figure 4 shows that the polymorphic population neutrally evolved to a 
markedly higher mutational robustness than the monomorphic populations, with 50 ± 2% 
of the final polymorphic population mutants continuing to function versus 39 ± 2% for 
the final monomorphic populations (Chi-square P-value of 10–3 that these values are the 
same). The only difference between the two types of populations was their size, so 
evolution has clearly favored mutational robustness in the larger and thus more 
polymorphic population. This finding represents the first experimental support for the 
prediction that highly polymorphic populations evolve excess mutational robustness [11].  
Figure 4 also indicates that the experiments have proceeded for a sufficient number of 
generations for the mutational robustness to equilibrate to its average value. Such 
equilibration is important because the populations all started from a single parent 
sequence, and so will take some number of generations to lose their “memory” of this 
starting sequence. Once this memory is lost, the mutational robustness should remain 
relatively constant around its average value, as appears to be the case in Figure 4. This 
figure also supports the notion that the polymorphic population is sufficiently large to be 
relatively well described by the deterministic equations given in the Appendix, as the 
fluctuations in its mutational robustness are small relative to the overall difference 
compared to the monomorphic populations. 
Theory predicts that the excess mutational robustness of a highly polymorphic protein 
population comes from increased protein stability [22]. Because the P450 variants unfold 
irreversibly, an equilibrium thermodynamic stability ∆Gf cannot be measured. We 
therefore determined stability to irreversible thermal and chemical denaturation, two 
highly correlated measures of P450 stability that have previously been shown to 
contribute to mutational robustness [5] (see Additional files 3–5). Figure 5 shows that 
proteins from the polymorphic population were in fact more stable than their counterparts 
from the monomorphic population (statistical tests showing that this difference is 
significant are given in the figure legend). We also observed that proteins in the 
polymorphic population tended to accumulate to higher levels in E. coli (Figure 5). 
Elevated expression could be a byproduct of increased stability, or it could independently 
increase mutational robustness by allowing the proteins to better tolerate mutations that 
decrease codon adaptation or reduce folding efficiency. Changes in P450 catalytic 
efficiency did not appear to be a major mechanism for the observed differences in 
mutational robustness, as we did not see any evidence of systematic differences between 
the polymorphic and monomorphic populations in the number of 12-pNCA turnovers per 
enzyme (see the detailed analysis in [26] and the Methods section of the present article). 
However, it is certainly possible that additional unrecognized biophysical factors 
contributed to the excess mutational robustness of the polymorphic population, although 
no such factors were immediately obvious. 
Interpretation in terms of the P450 neutral network 
The higher mutational robustness of the polymorphic population is due to the fact that it 
occupies the P450 gene neutral network differently than the monomorphic populations. 
Measurements from the evolution experiments can therefore be used to infer basic 
properties of the underlying neutral network of P450 genes, as originally noted by van 
Nimwegen and coworkers [11]. In the Appendix, we derive approximations for the 
normalized principal eigenvalue 〈ν〉∞ and the normalized average connectivity 〈ν〉o of the 
neutral network, where in both cases the normalization is obtained by dividing by the 
network coordination number. We obtain 〈ν〉∞ = 0.51 and 〈ν〉o = 0.35 for the P450 gene 
neutral network. Our ability to consistently estimate these two parameters from four 
different experimental measurements supports the idea that the theory that we elaborate 
in the Appendix appropriately describes the experiments. The difference between 〈ν〉∞ 
and 〈ν〉o is a measure of the extent to which some P450 neutral network nodes have more 
connections than others. We note that 〈ν〉∞ is approximately equal to the exponential 
decline parameter for the asymptotic decline in the fraction of functional mutants with 
increasing numbers of random nucleotide mutations [3,27,28] (see Appendix). Previous 
studies looking at this exponential decline have reported 〈ν〉∞ = 0.7 for subtilisin [27], 
〈ν〉∞ = 0.7 for 3-methyladenine DNA glycosylase [28], and 〈ν〉∞ = 0.7–0.8 for TEM1 β-
lactamase [3]. These comparisons suggest that P450 has a sparser neutral network 
(smaller 〈ν〉∞) than these other proteins. We suspect, however, that these earlier studies 
(one of which is our own) overestimate 〈ν〉∞ due to insufficient equilibration of the 
starting sequence. We believe that the approach of the current work is a more accurate 
method for determining 〈ν〉∞ because the measurements are made after many mutations 
have equilibrated the initial sequence. This approach could be used in future experiments 
to compare the neutral network connectivities of proteins from different families. 
Conclusions 
We have demonstrated that neutral evolution favors more mutationally robust proteins 
when the evolving population is highly polymorphic. Strikingly, the excess mutational 
robustness is due only to population polymorphism, and so will arise in any population of 
sufficiently large size. Our work is the first experimental demonstration of this 
phenomenon, which is predicted to occur quite generally in neutrally evolving proteins 
and nucleic acids [11]. Furthermore, we were able to identify one of the biophysical 
factors underlying the increase in mutational robustness by showing that proteins from 
the highly polymorphic population are more stable. We recognize, however, that 
evolution in a biological context will be more complex. In our experiments, fitness was 
considered to be the P450’s ability to be expressed in active form by bacteria grown to 
saturation in an environment with plentiful nutrients. Biological fitness, however, 
depends on numerous additional and subtle effects such as the metabolic costs of protein 
synthesis or the burdens imposed by misfolded molecules. Some mutations that are 
neutral in the experiments might therefore have deleterious effects in a biological 
setting [29]. The experiments nonetheless capture the overriding constraint that proteins 
retain their biochemical functions. Our success in quantitatively explaining the results 
supports the notion that important aspects of protein evolution can be described simply in 
terms of mutational effects on stability [22,29]. 
An obvious question is whether evolution in nature favors mutational robustness by the 
process we have demonstrated. Whether natural populations will evolve excess 
mutational robustness in their proteins depends on whether they are sufficiently 
polymorphic, which will be the case if the product of their effective population size N and 
per protein per generation mutation rate µ is much greater than one [11,12]. Accurately 
estimating Nµ, which is closely related to the widely used parameter θ in population 
genetics, for natural populations is difficult [30,31] (note that as mutational robustness is 
a protein-wide property, the relevant mutation rate is per protein, which is ≈102 to 103 
larger than the per codon mutation rate). For humans and other multicellular organisms, 
Nµ is probably too small [32] for their proteins to neutrally evolve mutational robustness. 
But estimates [32,33] place Nµ ≈ 10 to 100 for typical-length proteins in bacteria, and it 
is probably much higher for many viruses [34,35]. It therefore is likely that many viral 
and some bacterial proteins have evolved extra mutational robustness. It is important to 
note that this type of mutational robustness is due to changes in the internal properties 
(such as stability) of the proteins, and is limited by the “entropic force” caused by the 
constant rain of destabilizing mutations [22,24] rather than by any direct organismal 
fitness cost of maintaining the mutational robustness. By contrast, some other 
mechanisms of mutational robustness (such as gene redundancy) impose direct 
organismal fitness costs, and so will not necessarily be favored in large populations [36]. 
The fact that evolution favors protein mutational robustness in sufficiently large 
populations might also contribute to adaptive evolution. Experiments have shown that 
extra stability increases a protein’s evolvability by allowing it to tolerate a wider range of 
functionally beneficial but destabilizing mutations [5]. A similar phenomenon seems to 
occur in natural evolution, where functionally neutral but stabilizing mutations can play a 
key role in adaptive evolution by counterbalancing the destabilizing effects of other 
functionally beneficial mutations [37]. Viruses and perhaps bacteria might thus benefit 
from large population sizes and high mutation rates that drive an increase in the 
mutational robustness and stability of their proteins, which in turn enhances the capacity 
of these proteins to rapidly change their sequences and evolve new functions. 
Methods 
Equilibration evolution of the P450 protein 
We began with a 21B3 P450 peroxygenase that had been engineered for highly efficient 
hydroxylation of 12-pNCA [23] (see Additional file 6). This P450 was not well 
equilibrated to the constant selection criterion that we planned to impose, because it had 
substantially higher total activity. We therefore neutrally evolved it for 16 generations in 
order to create P450s that were better equilibrated to the selection criterion. We evolved 
two parallel populations, which we named R1 and R2. The procedure was exactly 
identical to that described below for the polymorphic evolution with the following 
exceptions. 
Starting sequence 
The starting sequence for the equilibration evolution was the 21B3 sequence. 
Population size 
Each of the two equilibration evolution populations had a size of 174 sequences rather 
than the 435 used for the polymorphic evolution. 
Selection criterion 
The sequences were required to have at least 75% of the total activity of the 21B3 P450. 
Mutation rate 
The mutation rate for the equilibration evolution was much higher than for the 
polymorphic evolution. The error-prone PCR protocol used 200 µM manganese chloride 
(MnCl2), rather than the 25 µM used for the polymorphic evolution. We estimate that this 
error-prone PCR protocol introduced ≈ 4 nucleotide mutations per P450 gene at each 
generation during the equilibration evolution. 
We performed 16 generations of equilibration evolution, and then randomly selected 23 
functional mutants from each of the R1 and R2 populations (see Additional file 7). We 
picked one of these mutants, R1–11, for use as the parent for the neutral evolution 
experiments. 
Detailed protocol for evolution experiments 
We began with the R1-11 P450 BM3 heme domain variant (see Additional file 1) cloned 
into the pCWori [25] plasmid with a 5’ BamH1 and 3’ EcoR1 site as described in [5]. The 
cloning primers were pCWori_for (5’-
GAAACAGGATCCATCGATGCTTAGGAGGTCAT-3’) and pCWori_rev_clone (5’-
GCTCATGTTTGACAGCTTATCATCG-3’). We used error-prone PCR to generate 
mutants, taking great care to make the error-prone PCR protocol repeatable by using a 
relatively small number of thermal cycles. This was both to control the mutation rate by 
ensuring that the reaction did not saturate the reagents, which would cause the number of 
doublings to become sensitive to the initial template concentration, and to avoid the PCR-
based recombination events that can occur during with the last few thermal cycles of PCR 
reactions [38,39]. The PCR reactions were 100 µl in volume, and contained ≈ 13 ng of 
plasmid template (corresponding to ≈3 ng of template gene), 7 mM MgCl2, 1 x Applied 
BioSystems PCR Buffer II without MgCl2, 25 µM MnCl2, 0.5 µM pCWori_for primer, 
0.5 µM pCWori_rev primer, 200 µM of dATP and dGTP, 500 µm of dTTP and dCTP, 
and 5 units of Applied Biosystems AmpliTaq polymerase. The reactions were run on the 
BLOCK setting of a MJ Research PCR machine with a program of 95 °C for 2 min, then 
15 cycles of (95 °C for 30 s, 57 °C for 30 s, 72 °C for 90 s), and then cooling to 4 °C. 
This protocol yielded roughly 1–1.5 µg of product gene (as quantified by gel 
electrophoresis versus a known standard), for a PCR efficiency of ≈0.5. Sequencing the 
unselected populations at the end of the experiment indicated that this protocol 
introduced an average of 1.4 ± 0.2 nucleotide mutations, with the nucleotide error-
spectrum shown in Table 1. Because the number of PCR doublings is large compared the 
average mutation rate, the distribution of mutations among sequences should be well 
described by the Poisson distribution [40,41].  
The mutant genes from the error-prone PCR were purified over a ZymoResearch DNA 
clean and concentrator column, and digested at 37 °C with EcoR1 and BamH1. The 
digested genes were then purified from an agarose gel with ZymoResearch DNA gel 
extraction columns, and ligated into pCWori plasmid that had been digested with BamH1 
and EcoR1 and dephosphorylated. The ligations were transformed into electro-competent 
catalase-free Escherichia coli [25] (the catalase is removed because it breaks down the 
hydrogen peroxide utilized by the P450 peroxygenase), plated on Luria Broth (LB) plates 
containing 100 µg/ml of ampicillin to select for the plasmid’s antibiotic resistance 
marker, and grown at 37 °C. Transformation of a control ligation reaction without any 
digested gene yielded at least 100-fold fewer colonies, indicating that the rate of plasmid 
self-ligation was less than one percent.  
Individual mutant colonies from the plates were picked into 96-well 2 ml deep-well 
plates containing 400 µl of LB supplemented with 100 µg/ml ampicillin. Each plate 
contained four parental control wells with cells carrying the parent R1-11 gene, four null 
control wells with cells carrying the pCWori plasmid without a P450 gene, and a non-
inoculated well to check for contamination. For the polymorphic population, we picked 
five such plates with all 87 other wells containing different mutants for a total population 
size of 5 x 87 = 435 mutants. For the 22 monomorphic populations (we began with 24 
populations but two had to be discarded due to contamination), we picked a single colony 
for growth and screening. For the unselected populations we picked a single colony for 
growth without screening. The LB deep-well plates were grown for 16–20 h at 30 °C, 
210 rpm, and 80% relative humidity in a Kuhner humidified shaker. To express the P450 
mutants, we prepared 2 ml deep-well plates containing 400 µl per well of terrific broth 
(TB) supplemented with 200 µM isopropyl β-D-thiogalactoside (IPTG), 100 µg/ml 
ampicillin, and 500 µM of δ-aminolevulinic acid. We used a pipetting robot to inoculate 
these TB plates with 100 µl from the LB plates. We stored the LB deep-well plates at 
4 °C, and grew the TB deep-well plates in the humidified shaker at 30 °C, 210 rpm, and 
80% relative humidity for 22–24 h. After this growth, the cells were harvested by 
centrifuging the TB deep-well plates at 4 000 g for 5 min and discarding the liquid. The 
cell pellets were flash-frozen in liquid nitrogen to aid in cell lysis.  
To lyse the cells for the assays, we resuspended the cell pellets in 300 µl of 100 mM [4-
(2-hydroxyethyl)-1-piperazinepropanesulfonic acid] (EPPS) (pH 8.2) with 0.5 mg/ml 
lysozyme and 4 units/ml of deoxyribonuclease by pipetting 40 times with the pipetting 
robot. We then incubated the plates at 37 °C for 30 min, again resuspended with the 
pipetting robot, and put back at 37 °C for an additional 30 min. We then pelleted the cell 
debris by centrifugation at 6 000 g for 5 min at 4 °C. The pipetting robot was used to 
dispense 80 µl of the clarified lysate into 96-well microtiter plates (Rainin). We prepared 
a 6 x stock of 1.5 mM 12-pNCA in 36% dimethyl sulfoxide (DMSO) and the EPPS 
buffer (the 12-pNCA was stored in the DMSO solution and combined with the buffer 
immediately before use). We used a multichannel pipette to add 20 µl of this substrate 
stock to each well of the microtiter plate. We briefly mixed the plates using the shake 
setting of a 96-well plate spectrophotometer, and read an absorbance baseline at 398 nm. 
We then immediately added 20 µl of a freshly prepared solution of 24 mM hydrogen 
peroxide in the EPPS buffer to initiate the reaction, and mixed again. The final reaction 
conditions were therefore the EPPS buffer with 6% DMSO, 4 mM hydrogen peroxide, 
and 250 µM 12-pNCA. After 40 min we quantified the amount of enzymatic product by 
the increase in absorbance at 398 nm. This absorbance increase is due to the 4-
nitrophenolate molecule released after the P450 hydroxylates the twelfth carbon of the 
12-pNCA molecule [23]. To score the mutants as functional or nonfunctional, we 
compared their gain in absorbance minus the median null control reading to that of the 
median parental control reading minus the median null control reading. All mutants that 
had at least 75% of the parental gain were scored as functional, all other mutants were 
scored as nonfunctional.  
We used the information from these assays to select the parents for the next generation. 
For the unselected population we did not require the mutants to be functional, so the 
selected mutant was used to start a 4 ml culture of LB with 100 µg/ml ampicillin, and the 
plasmid DNA was harvested with a mini-prep. This plasmid DNA was used as the 
template for the next round of error-prone PCR. Therefore, after the first generation the 
four unselected replicates diverged into four separate error-prone PCR reactions. These 
unselected replicates were evolved for a total of 12 generations, and were sequenced at 
every third generation.  
For the polymorphic population, all mutants that were functional contributed an equal 
amount of plasmid DNA as template for the next generation. In order to do this, we 
collected 50 µl of the culture from the LB deep-well plate for each mutant that was 
scored as functional. All of these LB aliquots were pooled, and then the plasmid DNA 
was collected with a mini-prep. The pool of plasmid DNA was used as template for the 
next generation’s error-prone PCR reactions. We performed 15 generations of evolution 
for this polymorphic population. Note that at each generation we are assaying 435 
mutants as part of the evolutionary procedure, so this provides information on mutational 
robustness. At every third generation, we also selected a random sample of functional 
mutants for sequencing. After 15 generations, we randomly selected 22 mutants for 
stability measurements and sequencing analysis. The random selections were made from 
all functional mutants with the Python computer language random number generator.  
For the monomorphic populations, at each generation we assayed just a single mutant. If 
that mutant was nonfunctional, then at that generation the population stayed at its original 
sequence. In that case, for the next generation we simply picked a new mutant from the 
previous generation’s plate of transformed mutants. If the mutant we screened was 
functional, then that mutant represented the new population. We therefore grew a 4 ml 
LB culture with 100 µg/ml of ampicillin, and collected the plasmid DNA with a mini-
prep. That plasmid DNA was then used as the template for the next generation’s error-
prone PCR reaction. We thus had 22 (originally 24, two were subsequently contaminated) 
independent monomorphic populations that were being evolved in parallel. Each was 
evolved for 25 generations, and at the end of these 25 generations we measured the 
stability of the final sequence of each population. Each time an assayed mutant was 
functional, we sequenced the new P450 gene. We also measured the average mutational 
robustness of the monomorphic populations at every fifth generation. To do this, we did a 
pooled mini-prep of equal volumes of LB cultures of all 22 replicates to obtain a equal 
mix of plasmid DNA. We then performed error-prone PCR on this mix, and assayed 435 
mutants to measure the fraction functional (see Additional file 2). 
Test for recombination during error-prone PCR 
During the polymorphic population evolution, we performed error-prone PCR on a mix 
of different plasmids. It is common for PCR on mixed templates to lead to recombination 
events during the reaction [38,39]. We attempted to reduce this recombination by using a 
small number of thermal cycles. However, in order to test for recombination, we analyzed 
the sequences of the final 22 selected members of the polymorphic population. There are 
a variety of statistical tests to detect recombination in a set of sequences. A comparison of 
these tests by Posada [42] found that the Max-Chi2 method developed by John Maynard 
Smith [43] performs well. A publicly available implementation of this method [44] is 
available from [45]. We used this implementation to analyze the 22 final polymorphic 
sequences, and the resulting P-value was 0.29 after 100 random permutations, indicating 
that there is not significant recombination. 
Measurement of P450 stabilities 
We measured the stabilities to both irreversible thermal and irreversible urea denaturation 
of the final (generation 25) member of each monomorphic population, as well as of the 
22 randomly selected members of the polymorphic population. As discussed in the 
supplementary information of [5], cytochrome P450 BM3 heme domains (and indeed 
most P450s) denature irreversibly, forcing us to use resistance to irreversible denaturation 
to quantify protein stability. The first stability measure is the T50, defined as the 
temperature at which half of the protein is denatured after a 10 min incubation. The 
second stability measure is the [urea]50, defined as the urea concentration at which half of 
the protein denatures after a 4 h room-temperature incubation. Each set of measurements 
(those of T50 and [urea]50) was performed on all of the mutants in the same day, and each 
mutant was treated identically. Therefore, it is possible to make accurate comparisons of 
the relative values of the measurements within the data set. However, the absolute values 
of the T50 and [urea]50 values might be less accurate. Therefore, care should be taken in 
comparing the absolute value of these measurements to those of other studies (such as 
[5]). 
Both the T50 and [urea]50 measurements were performed in clarified cell lysate. The 
protein was expressed using catalase-free E. coli [25] containing the encoding gene on 
the IPTG inducible pCWori [25] plasmid. We used freshly streaked cells to inoculate 
2 ml cultures of LB supplemented with 100 µg/ml of ampicillin, and grew these starter 
cultures overnight with shaking at 37 °C. We then used 0.5 ml from these starter cultures 
to inoculate 1 litre flasks containing 200 ml of TB supplemented with 100 µg/ml of 
ampicillin. The TB cultures were grown at 30 °C and 210 rpm until they reached an 
optical density at 600 nm of ≈ 0.9, at which point IPTG and δ-aminolevulinic acid were 
added to a final concentration of 0.5 mM each. The cultures were grown for an additional 
19 h, then the cells were harvested by pelletting 50 ml aliquots at 5 500 g and 4 °C for 
10 min, and stored at –20 °C. To obtain clarified lysate, each pellet was resuspended in 
8 ml of 100 mM EPPS (pH 8.2) and lysed by sonication, while being kept on ice. The cell 
debris was pelleted by centrifugation at 8 000 g and 4 °C for 10 min, and the clarified 
lysate was decanted and kept on ice.  
For the T50 measurements, 125 µl of clarified lysate from a single mutant was added to all 
12 wells in a row of a 96-well hard-shell thin-wall microplate (MJ Research). The plate 
was heated for 10 min using the gradient method of an Eppendorf Mastercycler gradient 
PCR machine, with the gradient set at either 33–45 °C or 46–58 °C (each mutant was 
exposed to both of these gradients), the machine on the BLOCK setting, and the heated 
lid set to 75 °C with the lid WAIT option. The plate was then cooled to 4 °C, removed 
from the PCR machine, and centrifuged at 5 500 g and 4 °C for 5 min to pellet any 
debris. A pipetting robot was used to dispense 80 µl of the supernatent into a 96-well 
microtiter plate (Rainin), and the amount of remaining properly folded P450 was 
quantified from the carbon monoxide difference spectrum as described below. The T50 
values were determined by fitting sigmoidal curves the percent of remaining protein (see 
Additional file 3). Our ability to accurately compare T50 values within the data set 
requires that each well in a given column of the gradient PCR machine be at the same 
temperature. We used a thermocouple to measure the temperature of the wells with the 
machine lid open, and confirmed that the wells were within a few tenths of a degree of 
the same temperature. Further evidence for the consistency of our T50 values comes from 
the fact that two independent measurements of the T50 for our R1-11 parent yielded 
values that differed by only 0.1 °C. However, the absolute values of the measured 
temperatures are less accurate. Thermocouple measurements indicated that, with the 
machine lid open, the wells were ≈ 1 °C cooler than the indicated temperature. We were 
unable to ascertain the temperatures with the heated lid closed, but based on comparisons 
water bath measurements, the temperatures with the lid closed slightly exceeded the 
indicated temperatures. 
For the [urea]50 measurements, 125 µl of the clarified lysate from a single mutant was 
added to all 12 wells in a row of a 96-well microtiter plate. A pipetting robot was then 
used to add and mix 125 µl of a 2 x solution of urea in 100 mM EPPS (pH 8.2) so that 
each subsequent column had a higher concentration of urea, and so that the final urea 
concentrations were those shown in Additional file 4. The plates were left on the bench at 
room temperature for 4 h, and the amount of remaining properly folded P450 was 
quantified from the carbon monoxide difference spectrum as described below. The 
[urea]50 values were determined by fitting sigmoidal curves to the percent of remaining 
protein. Evidence for the consistency of the [urea]50 measurements comes from the fact 
that two independent measurements of the [urea]50 for our R1-11 parent yielded values 
that differed by only 0.01 M. In addition, the [urea]50 and T50 values are highly correlated 
(see Additional file 5), indicating that they provide consistent measures of stability.  
For both the T50 and [urea]50 measurements, the folded P450 was quantified from the 
carbon monoxide difference spectrum [45]. The microtiter plates containing the P450 
samples were first used to read blank spectra at 450 and 490 nm using a Tecan Safire 2 
plate reader. The plates were then incubated for 10 min in an airtight oven with carbon 
monoxide. The plates were removed form the oven and 10 µl of 0.1 M sodium 
hydrosulfite in 1.3 M potassium phosphate (pH 8.0) was immediately added to each well. 
After 5–10 min, spectra were again read at 450 and 490 nm. The amount of P450 is 
proportional to the increase in the signal at 450 nm after this procedure minus the change 
in the signal at 490 nm. 
Comparison of enzymatic substrate turnovers 
Another possible source of difference between the P450s from the polymorphic and 
monomorphic populations is their catalytic efficiencies, measured as the total number of 
12-pNCA substrate turnovers per enzyme. It was not possible to directly extract accurate 
values for enzymatic turnovers from the high-throughput screening procedures used in 
this study, because the neutral evolution selection criterion was set at a point where the 
assay readings were just beginning to saturate the linear range (i.e., this criterion was at a 
point where doubling the enzyme concentration led to a less than twofold increase in the 
assay reading). However, we have recently completed a study that determined accurate 
per enzyme turnover values for most of the final neutrally evolved P450s from the 
polymorphic and monomorphic populations by constructing careful standard curves to 
ensure that values were taken from the fully linear range. This study analyzed the P450s 
on the substrate of 12-pNCA as well as a variety of “promiscuous” substrates [26]. This 
study measured the 12-pNCA turnovers for 18 of the final polymorphic P450 variants, 
and 16 of the final monomorphic P450 variants. The mean and standard deviations for the 
P450s from these two populations were 307±88 and 385±120 turnovers per enzyme, 
respectively, with experimental errors of about 10% (see [26] for full data). Based on 
these measurements, there do not appear to be substantial differences between the 
populations in the per enzyme turnovers on 12-pNCA. 
Appendix 
Mathematical background 
The first purpose of this appendix is to provide mathematical equations that describe the 
experiments. The second is to show how four measurements from the experiments can be 
used to calculate two quantities that describe the topology of the underlying protein 
neutral network. We will derive two equations for both quantitites, each in terms of a 
different measurement. The fact that the four equations will be seen to yield consistent 
results provides evidence for the accuracy of the following calculations. Our calculations 
are based on a view of neutral protein evolution as a process constrained by a stability 
threshold, a view that we originally introduced to explain experimental protein 
mutagenesis results [3]. 
The calculations closely parallel our earlier work [22], which is in turn based on a general 
theoretical treatment of evolution on neutral networks by van Nimwegen and 
coworkers [11]. These calculations will probably be most thoroughly understood by first 
reading those works. The primary difference between the current calculations and [22] is 
that previously we assumed that the per generation per protein mutation rate µ was <<1, 
so that at each generation a protein was either unmutated (with probability 1–µ) or 
experienced a single mutation (with probability µ). In contrast, here we allow the 
mutation rate to be arbitrarily large, so that a protein can experience multiple mutations in 
a single generation (in this sense the calculations resemble the generalization by 
Wilke [18] of [11]). Specifically, let fm be the probability that a protein experiences m 
mutations in a single generation. Here we derive results for arbitrary fm, and then 
approximations relevant to the form of fm in the experiments. In the limiting case of small 
mutation rate (where f0 = 1–µ, f1 = µ, and fm = 0 for m>1), the calculations here reduce to 
those in [22]. Proteins evolving in nature typically experience very low mutation rates, so 
[22] probably offers the best description of natural protein evolution. The calculations 
presented here are designed to specifically treat the evolutionary dynamics of the 
experiments.  
A protein’s thermodynamic stability is described by its free energy of folding, ∆Gf, with 
more negative values indicating more stable proteins. As described in several previous 
papers [3,5,22], we assume that selection requires a protein to fold with some minimal 
stability ∆Gfmin, so that a protein adequately folds if and only if ∆Gf≤∆Gfmin. The amount 
of extra stability a protein possesses relative to the stability threshold is given by 
∆Gfextra = ∆Gf–∆Gfmin; note that all folded proteins will have ∆Gfextra ≤0. We further 
assume that as long as ∆Gfextra ≤0, selection is indifferent to the exact amount of extra 
stability that a protein possesses (see [22] for a discussion of the limitations of this 
assumption). We conceptually divide the continuous variable of protein stability into 
small discrete bins of width b. Specifically, a protein is in bin i if it has ∆Gfextra between 
(1–i)b and –ib, where i = 1,2,.... Mutating a protein changes its stability by an amount 
∆∆G (defined as the stability of the mutant protein minus the stability of the initial 
protein), and so can move it to a new stability bin. In [22], we defined a matrix W with 
elements Wij giving the transition probabilities that a single mutation changes a protein’s 
stability from bin j to bin i. We noted that W could be computed from the distribution of 
∆∆G values for all single mutations, and argued that W remains fairly constant during 
neutral evolution as the distribution of ∆∆G values remains relatively unchanged. 
However, we emphasize that (as discussed in detail in [22]) the constancy of the ∆∆G 
distribution remains an assumption, albeit one that has now been shown to be quite 
accurate for lattice proteins [3,22,46] and provide a consistent theoretical explanation for 
a growing body of experimental results (the current work, and [3]). 
As we are allowing for larger mutation rates, and we must consider the possibility that a 
protein’s stability might change due to multiple mutations at a single generation. 
Therefore, we make a more general definition of Wij,m as the probability that m random 
mutations to a protein in stability bin j change its stability to bin i, and let Wm be the 
matrix with elements Wij,m. Note that Wm only describes mutations that cause transitions 
from one folded protein to another, as the stability bins i = 1,2,... all correspond to folded 
proteins. As before [22], we assume that Wm is roughly constant during evolution, 
meaning that the distribution of ∆∆G values for multiple mutations is roughly constant 
during neutral evolution. Note that if m = 1, then Wm is just the matrix W that can be 
computed from the distribution of single-mutant ∆∆G values [22]. We will now use the 
matrices Wm to calculate the following characteristics of a population that has evolved to 
equilibrium: the distribution of stabilities, the average number of mutations 〈m〉T 
accumulated after T generations, and the average fraction 〈F〉 of stably folded proteins in 
the population. We then introduce a few approximations (that should be quite accurate for 
the experimental work in this paper) that greatly simplify these calculations. Finally, we 
relate the calculations to properties of the underlying protein neutral network. 
As described generally by van Nimwegen and coworkers [11], the evolutionary dynamics 
depend on whether the evolving population tends to be monomorphic or highly 
polymorphic. When the per sequence per generation mutation rate µ is <<1, whether the 
population is mostly monomorphic or highly polymorphic is determined by the product 
of the population size N and µ: when Nµ<<1 the population is mostly monomorphic, and 
when Nµ>>1 the population is highly polymorphic. However, with multiple mutations 
per generation, Nµ is no longer an appropriate parameter to distinguish between mono- 
and polymorphism, because if the population size is sufficiently small the population can 
still be monomorphic even if there are multiple mutations per generation. Specifically, in 
one set of experiments we constrained the population to be monomorphic (by maintaining 
a population size of one), but still allowed the single protein in this population to 
experience more than one mutation at a generation. So we instead denote the populations 
as either monomorphic or polymorphic. We indicate quantities calculated for the 
monomorphic population by the subscript M (i.e. 〈F〉M) and those calculated for the 
polymorphic population by the subscript P (i.e. 〈F〉P). 
Monomorphic limit 
In the limit of a completely monomorphic population, all of the proteins are in a single 
stability bin. Let pi(t) be the probability that the population is in stability bin i at time t, 
and let p(t) be the column vector with elements pi(t). At each generation there is a 
probability f0 that there is no mutation that becomes fixed in the population, a probability 
of ∑m = 1∞fm∑jWij,mpj that the population experiences a mutational event (that could be a 
single mutation, or several simultaneous mutations) that moves it into bin i, and a 
probability ∑m = 1∞fmpi∑jWji,m that the population is in bin i and experiences one or more 
mutations that move it to another bin of stably folded proteins. Define νi,m = ∑jWji,m to be 
the fraction of m-mutants of a protein in bin i that still fold, and let Vm be the matrix with 
diagonal elements given by Vii,m = νi,m and all other elements zero. The time evolution of 
p is: 
 p(t+1) = [I+∑m = 1∞fm(Wm–Vm)]p(t) (1) 
where I is the identity matrix. Note that mutations that destabilize a protein beyond the 
stability threshold are immediately lost to natural selection, and so leave the population in 
its original stability bin. This describes the experiments for the monomorphic 
populations, where we retain the parental sequence if the single mutant we generate is 
nonfunctional. Equation 1 here corresponds to Equation 1 of [22], and the “blind ant” 
random walk described by van Nimwegen and coworkers [11]. Equation 1 describes a 
Markov process with a non-negative, irreducible, and acyclic transition matrix, and so p 
approaches a unique stationary distribution (equilibrium value) of pM given by the 
eigenvector equation: 
 pM = [I+∑m = 1∞fm(Wm–Vm)]pM (2) 
Once p has reached equilibrium, the average fraction of proteins that still stably fold at 
each generation is: 
 〈F〉M = e(f0I+∑m = 1∞fmWm)pM (3) 
where e = (1,...,1) is the unit row vector.  
To calculate 〈m〉T,M, the average number of mutations accumulated after T generations 
once the population has equilibrated, we note that at each generation there is a probability 
of fmpj∑iWij,m that a randomly chosen protein is in bin j, experiences m mutations, and still 
stably folds. The average number of mutations accumulated in a single generation is 
simply the average of m weighted over this probability. So summing over all values of m 
and j, we see that: 
 〈m〉T,M = Te∑m = 0∞mfmWmpM (4) 
This equation corresponds to Equation 6 of [22], which was derived using an embedded 
Markov process formalism. Here we have foregone this formalism for the more intuitive 
argument presented above, as we do not attempt to calculate higher moments of the 
number of mutations. 
Polymorphic limit 
In the limit when the population is highly polymorphic, at each generation there are 
sequences in many different stability bins. In this case, we describe the distribution of 
stabilities by the column vector x(t), with element xi(t) giving the fraction of proteins in 
stability bin i at time t. At generation t, the fraction of mutants that continue to fold is: 
 〈F〉t = e(f0I+∑m = 1∞fmWm)x(t) (5) 
Therefore, in order to maintain a constant population size, each remaining protein must 
produce an average of αt = 〈F〉t–1 offspring. The population therefore evolves according 
to: 
 x(t+1) = αt(f0I+∑m = 1∞fmWm)x(t). (6) 
After the population evolves for a sufficiently long period of time, x will approach an 
equilibrium value of xP. At this equilibrium, the average fraction of mutants that fold at 
each generation is: 
 〈F〉P = e(f0I+∑m = 1∞fmWm)xP (7) 
and the equilibrium reproduction rate is α = 〈F〉P–1. Therefore: 
 xP = α(f0I+∑m = 1∞fmWm)xP (8) 
Equations 7 and 8 can be combined to show that xP and 〈F〉P can be calculated from the 
eigenvector equation: 
 (〈F〉P–f0)xP = ∑m = 1∞fmWmxP (9) 
with (〈F〉P–f0) the principal eigenvalue of the nonnegative and irreducible matrix 
∑m = 1∞fmWm. Equation 9 corresponds to Equation 14 of [22], Equation 6 of the work by 
van Nimwegen and coworkers [11], and Equation 13 of the work by Wilke [18].  
We now calculate 〈m〉T,P, the average number of mutations accumulated in T generations 
after the population has equilibrated. At equilibrium, there is a probability of fmxj∑iWij,m 
that a protein is in bin j, experiences m mutations, and still stably folds. Subsequently, all 
of these folded proteins produce an average of α offspring. The average number of 
mutations accumulated in a single generation is simply the average of m weighted over 
this probability, and then multiplied by the average reproduction rate. So summing over 
all values of m and j, we obtain: 
 〈m〉T,P = αTe∑m = 0∞mfmWmxP = T/〈F〉P e∑m = 0∞mfmWmxP. (10) 
This equation is the counterpart of Equation 18 of [22], where we have again foregone 
the embedded Markov process formalism for a more intuitive derivation. 
Approximations for polymorphic limit 
We can dramatically simplify the results from the previous sections with several 
reasonable approximations. The first approximation is that the ∆∆G values for random 
mutations are roughly additive, and is supported by a number of experimental studies of 
the thermodynamic effects of mutations [47-49]. We have previously shown that this 
approximation can be used to accurately describe experimental protein mutagenesis data 
with a simple stability threshold model [3]. Under this approximation, the distribution of 
net ∆∆G values for multiple mutations can be computed from the distribution of ∆∆G 
values for single mutations by performing convolutions of the single-mutation ∆∆G 
distribution [3], meaning that Wm for arbitrary m can be computed solely from the 
distribution of ∆∆G values for single mutations. However, to simplify the equations from 
previous sections, we need to express Wm for arbitrary m only in terms of W (recall that 
W = W1). As W only contains information about stability transitions from folded 
proteins to other folded proteins, if we make the second approximation that a protein that 
is destabilized beyond the minimal stability threshold by one mutation is not re-stabilized 
to a folded protein by a subsequent mutation, then Wm = Wm. This approximation that 
unfolded proteins are not re-stabilized should be quite accurate as stabilizing mutations 
tend to be relatively rare and small in magnitude [50-53] (this is the underlying idea 
behind the Markov chain approximation that was shown to be highly accurate for lattice 
proteins [46]). To summarize, if ∆∆G values are roughly additive and stabilizing 
mutations are rare, we have the approximation: 
 Wm≈Wm. (11) 
Simplifying the equations of the previous sections also requires assigning a specific 
functional form to fm, the probability that a sequence undergoes m mutations. Here we 
assume that mutations are Poisson distributed among sequences, so that: 
 fm = e–µµm/m! (12) 
where µ = ∑m = 0∞mfm is the average number of mutations per protein per generation. 
When the mutations are introduced by error-prone PCR, the Poisson distribution is an 
excellent approximation to the true theoretical distribution of mutations created by error-
prone PCR [40,41] provided that µ is much less than the number of PCR doublings, as is 
the case in all of the experiments in the current work. We now use the approximations of 
Equations 11 and 12 to simplify the results given above for the highly polymorphic limit. 
We begin by using these approximations to rewrite Equation 9 as: 
 (〈F〉P–e–µ)xP = e–µ∑m = 1∞ µm/m! WmxP. (13) 
This equation makes clear that xP is the principal eigenvector of the matrix ∑m = 1∞ µm/m! 
Wm, therefore xP must also be the principal eigenvector of W. Now in our earlier 
work [22], we defined the principal eigenvector of W as x∞, called the corresponding 
eigenvalue 〈ν〉∞, and showed that this eigenvalue is the average fraction of single 
mutations that are neutral in a population that is evolving with Nµ>>1 and µ<<1. 
Therefore, with the approximation of Equation 11, xP and x∞ are equal, and are both 
defined by the same eigenvector equation: 
 〈ν〉∞xP = WxP = Wx∞ = 〈ν〉∞x∞. (14) 
Combining Equations 13 and 14, we have: 
 〈F〉PxP = e–µ∑m = 0∞ (µ〈ν〉∞)m/m! xP 
 = e
–µ(1–〈ν〉
∞
)xP. (15) 
Equation 15 can be solved to yield: 
 〈ν〉∞ = 1+ ln〈F〉P/µ (16) 
Similarly, we can simplify Equation 10 to: 
 〈m〉T,P = T/〈F〉P e∑m = 1∞mfmWmxP 
 = Teµ(1–〈ν〉∞)∑m = 1∞me–µ µm/m!eWmxP 
 = Te–µ〈ν〉∞∑m = 1∞m (µ〈ν〉∞)m/m! 
 = Tµ〈ν〉∞e–µ〈ν〉∞∑m = 0∞ (µ〈ν〉∞)m/m! 
 =  Tµ〈ν〉∞.  (17) 
Solving this equation for 〈ν〉∞ yields: 
 〈ν〉∞ = 〈m〉T,P/(Tµ). (18) 
Approximations for monomorphic limit 
We now simplify the equations for the monomorphic limit. This requires several further 
approximations. We begin by approximating that the stability probability distribution pM 
given by Equation 2 by the distribution po defined in [22] as satisfying: 
 0 = (W–V)po. (19) 
The basic rationale behind approximating pM with po is that Equation 2 can be viewed as 
a perturbation to Equation 19 [54]. Essentially, po is an eigenvector of the matrix W–V 
while pM is the corresponding eigenvector of the matrix W–V+∑m = 2∞ µm–1/m! (Wm–Vm). 
The latter matrix can be viewed as a perturbation to the first, as the sum ∑m = 2∞ µm–1/m! 
(Wm–Vm) is small. This smallness is due to the fact that Wm tends to zero with large m, 
causing Vm to tend towards the identity matrix. In addition, the µm/m! terms tend to zero 
with large m. Therefore, the terms in the summation are all simply either a perturbation to 
W–V or involve subtracting terms that are fractions of the identity matrix. The 
perturbations lead to bounded changes in the eigenvectors [54], while the identity matrix 
terms do not change the eigenvectors. Below, we give a more rigorous justification of the 
assumption that pM is approximately equal to po.  
We need one additional approximation to make further progress. Both Equations 3 and 4 
contain terms of the form Wmpo, and even if we use Equation 11 to rewrite these terms as 
Wmpo, there are no further clear simplifications. However, any probability vector that is 
multiplied repeatedly by W and normalized will eventually converge to x∞ = xP (as this is 
the principal eigenvector of W). We make the approximation that this convergence is 
sufficiently rapid to be essentially complete after a single multiplication. This 
approximation is supported by both protein mutagenesis studies [3,27,28] that indicate 
that proteins rapidly converge to an exponential decline in the fraction folded (indicating 
the stability distribution has equilibrated, as discussed below, and by lattice protein 
studies showing the same [3,46]. Therefore, we make the approximation that 
eWmpo = 〈ν〉oeWm–1x∞ = 〈ν〉o〈ν〉∞m–1 where 〈ν〉o = eWpo has the same definition as in [22], 
where it was defined as the average fraction of functional single mutants of a population 
evolving with µ<<1 and Nµ<<1. We use these approximations to simplify Equation 3 to: 
 〈F〉M = e(f0I+∑m = 1∞fmWm)pM 
 = e
–µ[1+∑m = 1∞ µm/m! eWmpo] 
 = e
–µ[1+µ〈ν〉o∑m = 1∞ (µ〈ν〉∞)m–1/m! ] 
 = e
–µ[1+ 〈ν〉o/〈ν〉∞ (–1+∑m = 0∞(µ〈ν〉∞)m/m! )] 
 = e
–µ[1+ 〈ν〉o/〈ν〉∞ (eµ〈ν〉∞–1)]. (20) 
Solving this equation for 〈ν〉o, we find: 
 〈ν〉o = 〈ν〉∞(〈F〉Meµ–1)/(eµ〈ν〉∞–1). (21) 
We now use the approximations to simplify Equation 4 to: 
 〈m〉T,M = Te∑m = 0∞mfmWmpM 
 = Te–µ∑m = 1∞m µm/m! eWmpo 
 = Te–µ〈ν〉o∑m = 1∞m µm/m! 〈ν〉∞m–1 
 = µTe–µ〈ν〉o∑m = 0∞ (µ〈ν〉∞)m/m! 
 = µT〈ν〉oeµ(〈ν〉∞–1). (22) 
Solving this equation for 〈ν〉o yields: 
 〈ν〉o = 〈m〉T,Meµ(1–〈ν〉∞)/(µT). (23) 
To recap, we now have equations to calculate 〈ν〉∞ and 〈ν〉o from experimentally 
measurable quantities. Equations 16 and 18 allow us to calculate 〈ν〉∞ from 〈F〉P and 
〈m〉T,P, respectively. Given this calculated value of 〈ν〉∞, Equations 21 and 23 then allow 
us to calculate 〈ν〉o from 〈F〉M and 〈m〉T,M, respectively. The fact that we have two 
equations each for 〈ν〉∞ and 〈ν〉o allows us to assess the self-consistency of the approach. 
Interpretation in terms of neutral networks 
Throughout the preceding calculations, we have referred to 〈ν〉∞ and 〈ν〉o as we defined 
them in [22]: namely, as the average neutrality of protein populations evolving with µ<<1 
and Nµ either >>1 or <<1, respectively. However, van Nimwegen and coworkers [11] 
have shown that they can also be interpreted in terms of the underlying neutral network. 
In the experiments, we make mutations at the nucleotide (rather than amino acid) level, 
so each point in our sequence space corresponds to a different gene. Every gene that 
yields an amount of protein sufficient to hydroxylate the twelfth carbon of 12-p-
nitrophenoxydodecanoic acid with at least 75% of the total activity conferred by the 
original R1-11 parent gene represents a node on this neutral network. We note that in the 
experiments (and also usually in natural evolution), the edges on the neutral network are 
not all completely equivalent or fully undirected, as some mutations are more likely to 
occur than others (for example, error-prone PCR with Taq polymerase is more likely to 
cause an A→G mutation than an A→C mutation). In the analysis that follows, we ignore 
this complication and assume all neutral network edges are equivalent. 
In an extremely insightful analysis, van Nimwegen and coworkers [11] have shown that 
important characteristics of a neutral network can be inferred from evolutionary 
quantities. Specifically, they have shown that if a population is evolving with µ<<1 and 
Nµ>>1, then the average neutrality (that we have denoted by 〈ν〉∞) is equal to the 
principal eigenvalue of the adjacency matrix of the neutral network, normalized by the 
network coordination number (number of possible connections per node). In addition, 
they pointed out that a population evolving with µ<<1 and Nµ<<1 moves like a blind ant 
random walk, meaning that the average neutrality (that we have denoted by 〈ν〉o) is equal 
to the average connectivity of a neutral network node divided by the network 
coordination number.  
In our P450 experiments, we have measured the values needed to estimate 〈ν〉∞ and 〈ν〉o 
using Equations 16, 18, 21, and 23. Using the final values listed in Table 2, 〈F〉P = 0.50 
and 〈F〉M = 0.39. Taking the final nucleotide mutation values from Table 2, 
〈m〉T,P/T = 0.69 and 〈m〉T,M/T = 0.31. The average mutation rate, computed from the 
unselected population, is µ = 1.4. So using Equation 16, 〈ν〉∞ = 0.53, while using 
Equation 18, 〈ν〉∞ = 0.49. The consistency of these two values supports the idea that the 
calculations above accurately describe the evolutionary process. Taking the average value 
of these two measurement as 〈ν〉∞ = 0.51, we can then use Equations 21 and 23 to 
calculate 〈ν〉o. We calculate values of 0.28 and 0.43, respectively. These estimates differ 
by more than those for 〈ν〉∞, perhaps because additional approximations have gone into 
the derivation of the relevant equations (in addition, we have made no attempt to carry 
out the rather complex propagation of the sampling errors of Table 2). However, the 
values are still in a similar range. Taking the average of these two values, we estimate 
that 〈ν〉o = 0.35. So overall, we predict that each functional P450 gene should have an 
average fraction of 0.35 of its sequence nearest neighbors also encoding a functional 
gene, for an average of about 1,500 neighbor genes. We predict that the principal 
eigenvalue of the neutral network adjacency matrix is 0.51 x 3L. The fact that principal 
eigenvalue exceeds the average connectivity indicates that the neutral network is not a 
regular graph, but instead has some nodes more highly connected than others. 
The value for 〈ν〉∞ calculated above can also be related to measurements from protein 
mutagenesis experiments. A number of studies [3,27,28] have observed that the 
probability that a protein remains functional after m mutations falls off exponentially with 
the number of mutations. In fact, the decline is not always exponential for the first few 
mutations if the starting protein has especially high or low stability [3] or activity [55], 
but will still converge to this exponential form after a few mutations [3,46,56]. The 
stability threshold model can be used to relate this decline to 〈ν〉∞, as is performed 
indirectly in the Markov chain approximation of [46]. Here we make that connection 
explicit. The initial protein has a stability that falls into some stability bin i. Therefore, its 
stability can be described by the column vector y0, which has element i equal to one and 
all other elements equal to zero. Now imagine constructing all single mutants of this 
protein. The fraction of these single mutants that still fold is just eWy0, and the 
distribution of stabilities among the single mutants is y1 = Wy0 (note that the elements of 
y1 no longer sum to one). Similarly, after m mutations, the fraction of mutants that still 
fold is eWmy0, and the distribution of stabilities among the m-mutants is ym = Wmy0. 
With the approximation of Equation 11, ym = Wmy0. This makes it clear that ym will 
converge to a vector proportional to x∞, the principal eigenvector of W. Once this 
convergence is complete, each new mutation simply reduces the fraction of mutants that 
fold by a factor of 〈ν〉∞, the principal eigenvalue of W (and the spectral radius of the 
neutral network normalized by the coordination number). Therefore, what we have called 
〈ν〉∞ in the present work and [22] is equal to what is called x in [28], q in [27], and 〈ν〉 in 
[3]. The major difficulty that is faced in extracting 〈ν〉∞ by the method of those three 
studies [3,27,28] is that it is not possible to directly assay mutants with m mutations, but 
instead only possible to assay a set of mutants with a distribution of m. All three studies 
use different (and valid) methods to account for this distribution, but this accounting is 
still difficult because most of the functional mutants come from the low m end of the 
distribution. This makes it difficult to ascertain accurate values for the fraction functional 
after large numbers of mutations, as most of the functional mutants in the set come from 
sequences with few mutations. For this reason, we believe the current method of 
measuring 〈ν〉∞ is more accurate. A second caution about comparing values of 〈ν〉∞ from 
different studies is that its value depends on the nucleotide error-spectrum of the 
experiment, as different mutagenesis methods create different distributions of nucleotide 
and amino acid mutation types. 
We also briefly mention how we arrived at an estimate of 〈ν〉∞ for 3-methyladenine DNA 
glycosylase from the data of [28]. This paper reports that a fraction x = 0.34 of amino 
acid mutations inactivate the protein. We would like to determine the fraction 〈ν〉∞ of 
nucleotide mutations that do not inactivate the protein. Roughly 75% of random 
mutations to a gene will be synonymous. Therefore, m amino acid mutations should 
cause about 4m/3 nucleotide mutations. The study of [28] measures that after m 
mutations, a fraction (1–x)m of the mutants are functional. That means that 〈ν〉∞4m/3 
fraction should be functional. Equating these expressions yields 〈ν〉∞ = exp( 3/4 log(1–x)). 
So using x = 0.34, we arrive at 〈ν〉∞ = 0.73. 
Detailed justification for approximating pM by po 
Here we provide a detailed justification for the approximation that pM is about equal to 
po. In the monomorphic limit, the time evolution of p is given by Equation 1, and the 
stationary distribution pM is given by Equation 2. We assume the approximations of 
Equations 11 and 12 and show that we can approximate pM by po, where po is given by 
Equation 19. To justify this approximation, we insert po into the righthand side of 
Equation 1 and ask to what extent po is left unaltered by the dynamics. If po is found to be 
stationary to good approximation then, by uniqueness of the stationary distribution of an 
ergodic process, po would be a good approximation to pM. We therefore suppose that at 
some time t the distribution is given by po and compute, using Equation 1, the change in 
po after one generation. The new distribution at time t+1 is given by: 
 p(t+1) = [I+∑m = 1∞fm(Wm–Vm)]po (24) 
Using (V–W)po = 0, and taking components of the above equation, we obtain: 
 pi(t+1) = p0i+∑m = 2∞fm[(Wm–Vm)po]i (25) 
Thus, po would be an approximately stationary distribution of the dynamics if 
|∑m = 2∞fm[(Wm–Vm)po]i|<<p0i. We now proceed to show that this will be the case in most 
situations of interest by deriving upper and lower bounds on the second term of the 
righthand side of Equation 25.  
Consider first the term (Wmpo)i, which can be written as 
 (Wmpo)i =  ∑k1,...,km Wik1 Wk1k2 ··· Wk(m-1)km p0km 
   =  ∑k1,...,k(m-1) Wik1 Wk1k2 ··· Wk(m-2)k(m-1) νk(m-1) p0k(m-1), (26) 
where we have used Wpo = Vpo in the second equality. We now note that νk≤νmax for all 
k, where νmax is the maximum neutrality, maximized over all bins. This leads to the 
successive inequalities: 
 (Wmpo)i ≤ νmax ∑k1,...,k(m-1) Wik1 Wk1k2 ··· Wk(m-2)k(m-1) p0k(m-1) 
 = νmax ∑k1,...,k(m-2) Wik1 Wk1k2 ··· Wk(m-3)k(m-2) νk(m-2) p0k(m-2) 
 ≤ ν2max ∑k1,...,k(m-2) Wik1 Wk1k2 ··· Wk(m-2)k(m-1) p0k(m-1) 
 
≤ νm-1max ∑k1 Wik1 p0k1, (27)  
yielding the upper bound: 
 (Wmpo)i≤νmaxm–1νip0i. (28) 
In an identical manner, we obtain the lower bound: 
 (Wmpo)i≥νminm–1νip0i, (29) 
where νmin is the smallest neutrality, minimized over all bins. Note that both inequalities 
above become exact equalities when all bins have the same neutrality ν, which could be 
interpreted as either νmin or νmax.  
Having obtained inequality constraints on (Wmpo)i, we now consider the term (Vmpo)i, 
which can be written as: 
 (Vmpo)i = p0iνi,m 
 = p0i ∑j (Wm)ji 
 = p0i ∑j,k1,…,k(m-1) Wjk1 Wk1k2 ··· Wk(m-1)i 
 = p0i ∑k1,…,k(m-1) νk1 Wk1k2 ··· Wk(m-1)i 
 ≤ p0i νmax ∑k1,...,k(m-1) Wk1k2 ··· Wk(m-1)i 
 ≤ p0i νm-1max ∑k(m-1) Wk(m-1)I, (30) 
that yields an identical upper bound to that on (Wmpo)i, namely: 
 (Vmpo)i≤νmaxm–1νip0i (31) 
and similarly: 
 (Vmpo)i≥νminm–1νip0i. (32) 
It should again be noted that both the above inequalities become exact equalities when all 
bins have a common neutrality ν.  
We are now in a position to estimate bounds on the magnitude of the second term of 
Equation 25. Using the four inequalities of Equations 28, 29, 31, and 32 above, we have: 
 –(νmaxm–1–νminm–1)νip0i≤[(Wm–Vm)po]i≤(νmaxm–1–νminm–1)νip0i, (33) 
Or equivalently: 
 |[(Wm–Vm)po]i|≤(νmaxm–1–νminm–1)νip0i, (34) 
where the inequality above becomes an exact equality when all bins have the same 
neutrality. However, in this limit, the righthand side of the above equation vanishes, and 
therefore the second term of Equation 25 is identically zero in this case, giving the result 
that pM is exactly equal to po when all bins have the same neutrality, even if µ is 
arbitrarily large.  
We now carry out the sum over m to obtain an upper bound on the second term of 
Equation 25 in the more general and realistic case of unequal neutrality bins. Using 
Equation 34 and the specific Poisson form of fm, we obtain an upper bound on the 
fractional change in p0i in one generation: 
 |[pi(t+1) - p0i] / p0i| ≤ νi e–µ ∑m=2∞ µm/(m!) (νmaxm–1–νminm–1) 
 = νi e
–µ
 [(exp(µνmax) – 1)/ νmax - (exp(µνmin) – 1)/ νmin]. (35) 
The above bound vanishes for small µ, is an increasing function of νmax–νmin, and is 
typically much smaller than 1. An extreme estimate of the size of the fractional change 
can be made when νmax = 1 and νmin = 0. In this case, using µ = 1.4 (the value in our 
experiments), the above inequality simplifies to: 
 |pi(t+1)–p0i/p0i|≤νi(1–e–µ–µe–µ) ≈ 0.41νi. (36) 
Noting that νi<1, the fractional change in p0i is therefore reasonably controlled even in 
the most extreme case. For realistic situations, the fractional change in p0i is expected to 
be much lower, thus justifying the use of po as the stationary distribution of the dynamics 
of Equation 1. 
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Figures 
Figure 1 
Theoretical views of the evolution of protein mutational robustness and stability. (A) 
Theory predicts that a mostly monomorphic population is equally likely to occupy any 
node of its neutral network, while a highly polymorphic population will prefer more 
connected nodes [11]. Node sizes are drawn proportional to the occupation probabilities. 
(B) Proteins evolving in a highly polymorphic population are predicted to be more stable 
than their counterparts in a mostly monomorphic population [22]. The histograms 
illustrate the distributions of stabilities for the two cases. The increased stability is a 
biophysical manifestation of excess mutational robustness, as more stable proteins are 
more mutationally robust [3-5]. 
Figure 2 
Outline of the neutral evolution experimental procedure. For the polymorphic 
population, error-prone PCR was used to generate mutant P450 genes. These genes were 
ligated into a plasmid and transformed into E. coli. Individual mutants (435) were picked, 
expressed in E. coli, and assayed for enzymatic activity. All mutants that met the 
selection criterion contributed an equal amount of plasmid DNA as template for the next 
generation of error-prone PCR. The monomorphic populations were treated similarly, 
except only a single mutant was assayed at each generation. If this mutant met the 
selection criterion then it became the template for the next generation of error-prone 
PCR; otherwise at the next generation another colony was picked from the same plate. In 
the unselected populations a single mutant was picked and used as the template for the 
next generation of error-prone PCR. 
Figure 3 
Accumulation of nucleotide (〈mnt〉) and nonsynonymous (〈maa〉) mutations in the 
experimentally evolved P450 populations. For the unselected and monomorphic 
populations, numbers are the average over all replicates at the indicated generation; for 
the polymorphic population they are from a random sample, with sampling standard error 
shown. 
Figure 4 
Polymorphic populations neutrally evolve a higher average mutational robustness 
than monomorphic populations. The fraction functional was determined by assaying 
435 mutants (average of 1.5 nucleotide mutations per gene). Error bars show binomial 
standard error. For the monomorphic population, numbers are the average over all 
replicates. 
Figure 5 
More mutationally robust proteins are more stable. The P450s from the polymorphic 
population neutrally evolved higher stability and expression levels than their counterparts 
from the monomorphic populations. The histograms show the distributions for the final 
protein from all monomorphic replicates and for the same number of randomly chosen 
proteins from the final polymorphic population. The plots show (left to right) the 
temperature at which half the protein irreversibly denatured after 10 min (T50), the urea 
concentration at which half the protein denatured after 4 h ([urea]50), and the expression 
level relative to that of the original parental P450. The means are significantly different, 
with unequal variance t-test P-values of 0.02, 0.005, and 0.04, respectively. 
Tables 
Table 1: Error-prone PCR nucleotide mutation spectrum. The spectrum was 
determined by sequencing the four final (generation 12) sequences from the 
unselected population, as in these sequences the mutations accumulate without 
constraint. As has been previously noted for error-prone PCR with Taq 
polymerase [3,5,27], the nucleotide error spectrum is biased towards certain types 
of mutations. 
 
Parameter Value 
Total nucleotide mutations 67 
% Synonymous mutations 25 
Mutation types (%)  
A→T, T→A 19.4 
A→C, T→G 1.5 
A→G, T→C 64.2 
G →A, C→T 4.5 
G →C, C→G 0.0 
G →T, C→A 1.5 
Frameshift 9.0 
 
 
 
 
Table 2: Neutral evolution robustness and mutation data. Each row represents a 
different generation, T. NA indicates that no measurement was made. The <mnt> and 
<maa> are the average number of nucleotide mutations and nonsynonymous 
mutations, respectively. Numbers in parentheses are total counts over the total 
samples. Subscripts indicate the population type: U for unselected, P for 
polymorphic, and M for monomorphic. For the unselected and monomorphic 
populations, numbers represent averages of all replicates. For the polymorphic 
population, numbers are for a random sample of functional mutants. <F>P and 
<F>M are the fraction of functional 
 
T <mnt>U <maa>U <mnt>P <maa>P <mnt>M <maa>M <F>P <F>M 
0 0 0 0 0 0 0 0.48 (210 / 435) 0.48 (210 / 435) 
1 NA NA NA NA 0.1 (3 / 22) 0.3 (6 / 22) 0.48 (208 / 435) NA 
2 NA NA NA NA 0.4 (9 / 22) 0.8 (17 / 22) 0.49 (215 / 435) NA 
3 5.0 (20 / 4) 3.5 (14 / 4) 2.7 (27 / 10) 1.4 (14 / 10) 1.0 (23 / 22) 0.4 (9 / 22) 0.49 (215 / 435) NA 
4 NA NA NA NA 1.5 (32 / 22) 0.7 (15 / 22) 0.48 (208 / 435) NA 
5 NA NA NA NA 2.2 (48 / 22) 1.1 (25 / 22) 0.45 (197 / 435) 0.43 (185 / 435) 
6 9.8 (39 / 4) 7.5 (30 / 4) 5.5 (55 / 10) 2.1 (21 / 10) 2.6 (58 / 22) 1.4 (31 / 22) 0.46 (198 / 435) NA 
7 NA NA NA NA 3.1 (69 / 22) 1.8 (39 / 22) 0.52 (227 / 435) NA 
8 NA NA NA NA 3.4 (74 / 22) 1.8 (40 / 22) 0.46 (200 / 435) NA 
9 13.0 (52 / 4) 10.3 (41 / 4) 6.7 (61 / 9) 3.1 (28 / 9) 3.7 (82 / 22) 2.1 (46 / 22) 0.47 (203 / 435) NA 
10 NA NA NA NA 4.2 (92 / 22) 2.4 (52 / 22) 0.46 (199 / 435) 0.40 (175 / 435) 
11 NA NA NA NA 4.6 (102 / 22) 2.5 (56 / 22) 0.48 (207 / 435) NA 
12 16.8 (67 / 4) 12.5 (50 / 4) 7.8 (70 / 9) 3.3 (30 / 9) 4.9 (107 / 22) 2.6 (58 / 22) 0.52 (228 / 435) NA 
13 NA NA NA NA 5.0 (110 / 22) 2.7 (60 / 22) 0.52 (227 / 435) NA 
14 NA NA NA NA 5.3 (116 / 22) 2.9 (64 / 22) 0.50 (216 / 435) NA 
15 NA NA 10.3 (227 / 22) 3.8 (83 / 22) 5.6 (123 / 22) 3.0 (67 / 22) 0.50 (219 / 435) 0.39 (171 / 435) 
16 NA NA NA NA 5.8 (127 / 22) 3.0 (67 / 22) NA NA 
17 NA NA NA NA 6.0 (133 / 22) 3.1 (69 / 22) NA NA 
18 NA NA NA NA 6.3 (137 / 22) 3.2 (71 / 22) NA NA 
19 NA NA NA NA 6.3 (138 / 22) 3.3 (72 / 22) NA NA 
20 NA NA NA NA 6.6 (145 / 22) 3.4 (75 / 22) NA 0.37 (160 / 435) 
21 NA NA NA NA 6.9 (152 / 22) 3.6 (79 / 22) NA NA 
22 NA NA NA NA 7.1 (156 / 22) 3.7 (81 / 22) NA NA 
23 NA NA NA NA 7.2 (158 / 22) 3.7 (81 / 22) NA NA 
24 NA NA NA NA 7.3 (161 / 22) 3.8 (83 / 22) NA NA 
25 NA NA NA NA 7.7 (169 / 22) 4.0 (87 / 22) NA 0.39 (169 / 435) 
 
Additional files 
Additional file 1 - Sequence of the parent P450 used start neutral evolution. 
FASTA file with sequence of the R1-11 P450 BME used as the neutral evolution parent. 
This sequence was isolated after the equilibration evolution. 
 
Additional file 2 - Information about sequences from neutral evolution experiments. 
The entries give the name of the mutant, the number of nonsynonymous and nucleotide 
mutations relative to the R1-11 parent, the [urea]50 value if measured, the T50 value if 
measured, the percent of the parental expression level if measured, and then a list of all of 
the mutations. Amino acid mutations are numbered in the standard P450 numbering 
scheme. The names of the mutants indicate their origin. Names beginning with “P-G3” 
are randomly chosen functional mutants from generation 3 of the polymorphic 
population, etc. Names of the form “P1,” “P2,”, etc. are the 22 functional mutants that 
were randomly chosen from the final (generation 15) polymorphic population. Numbers 
P5 and P12 are missing because two of the original 24 randomly selected polymorphic 
population members were randomly chosen to be discarded after it was discovered that 
two of the 24 monomorphic replicates were contaminated. Names beginning with “U1” 
indicate that sequences are from the first unselected replicate, etc. Names beginning 
“M1” indicate sequences are from the first monomorphic replicate, etc. Replicates “M9” 
and “M10” were discarded due to contamination during the experiment. For each 
replicate, we sequenced each new functional mutant. The last functional mutant after 25 
generations represents the final sequence for that replicate, and is given an abbreviated 
name without the generation suffix. 
 
Additional file 3 - Thermostability measurements. 
Raw data from the T50 thermostability measurements. 
 
Additional file 4 - Urea stability measurements. 
Raw data from the [urea]50 thermostability measurements. 
 
Additional file 5 - Correlation of thermal and urea stabilities. 
The T50 and [urea]50 values are highly correlated. 
 
Additional file 6 - Sequence of initial P450 used to start equilibration evolution. 
FASTA file with sequence of the 21B3 P450 BM3 heme domain described in [23]. This 
P450 was used as the initial parent to start the equilibration evolution. 
 
Additional file 7 - Mutations accumulated during equilibration evolution. 
The file lists the mutations in the 46 P450 variants selected at the end of the equilibration 
evolution. Each line gives the name of the variant, with the prefix indicating whether it 
came from the R1 or R2 population. The next entries give the number of nucleotide and 
nonsynonymous mutations. All of the individual mutations relative to 21B3 are then 
listed. Amino acid mutations are numbered in the standard P450 numbering scheme, with 
the threonine after the N-terminal methionine given the number one. 
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Additional files provided with this submission:
Additional file 1: parent_p450_r1-11_sequence.fasta, 2K
http://www.biomedcentral.com/imedia/1329052369135346/supp1.fast
Additional file 2: evolution_data.txt, 43K
http://www.biomedcentral.com/imedia/2604971313534679/supp2.txt
Additional file 3: thermostabilities.pdf, 173K
http://www.biomedcentral.com/imedia/2012268575135346/supp3.pdf
Additional file 4: urea_stabilities.pdf, 132K
http://www.biomedcentral.com/imedia/1729851722135346/supp4.pdf
Additional file 5: t50_u50_correlation.pdf, 50K
http://www.biomedcentral.com/imedia/1493030806135346/supp5.pdf
Additional file 6: initial_p450_21b3_sequence.fasta, 1K
http://www.biomedcentral.com/imedia/5187958671353467/supp6.fast
Additional file 7: equilibration_mutations.txt, 20K
http://www.biomedcentral.com/imedia/3085254781353468/supp7.txt
